Literature DB >> 17374947

Increased QT dispersion in sickle cell disease: effect of pulmonary hypertension.

Ferit Akgül1, Ergün Seyfeli, Ismet Melek, Taşkin Duman, Tunzale Seydaliyeva, Edip Gali, Fatih Yalçin.   

Abstract

BACKGROUND: QT dispersion has been proposed to be a predictor of adverse outcomes in a variety of cardiac disease states. The objective of this study was to examine QT dispersion in patients with sickle cell disease (SCD) and to assess the effect of pulmonary hypertension (PHT) on QT dispersion.
METHODS: We performed Doppler echocardiographic assessments of pulmonary artery systolic pressure in 73 (mean age 18.5 +/- 8.0 years) steady-state SCD patients and 25 (mean age 19.6 +/- 7.2 years) healthy subjects. Resting 12-lead electrocardiogram was recorded and QT dispersion was calculated as the difference between maximum and minimum QT intervals. Bazett's formula was used to obtain a rate-corrected value of the QT interval (QTc).
RESULTS: Maximum QTc, minimum QTc and QTc dispersion were significantly increased in SCD patients compared to the control subjects (p < 0.0001, p < 0.05, p < 0.0001, respectively). Among SCD patients, patients with PHT had higher maximum QTc and QTc dispersion than patients without PHT (p < 0.0001). However, minimum QTc showed no significant differences between the two patient groups.
CONCLUSION: QTc dispersion is significantly increased in SCD patients, especially those with PHT indicating regional inhomogeneity of ventricular repolarization. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17374947     DOI: 10.1159/000100929

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  15 in total

1.  Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension.

Authors:  Zhang Hong-liang; Luo Qin; Liu Zhi-hong; Zhao Zhi-hui; Xiong Chang-ming; Ni Xin-hai; He Jian-guo; Wei Ying-jie; Zhang Shu
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Electocardiographic findings in adult Nigerians with sickle cell anaemia.

Authors:  N I Oguanobi; B J C Onwubere; S O Ike; B C Anisiuba; E C Ejim; O G Ibegbulam
Journal:  Afr Health Sci       Date:  2010-09       Impact factor: 0.927

3.  Dispersion durations of P-wave and QT interval in children with congenital heart disease and pulmonary arterial hypertension.

Authors:  Fatih Sap; Zehra Karataş; Hakan Altin; Hayrullah Alp; Bülent Oran; Tamer Baysal; Sevim Karaarslan
Journal:  Pediatr Cardiol       Date:  2012-09-13       Impact factor: 1.655

4.  QT dispersion in patients with pulmonary embolism.

Authors:  Necip Ermıs; Hilal Ermıs; Nazan Sen; Alper Kepez; Bilal Cuglan
Journal:  Wien Klin Wochenschr       Date:  2010-12-10       Impact factor: 1.704

5.  QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.

Authors:  Jonathan D Rich; Thenappan Thenappan; Benjamin Freed; Amit R Patel; Ronald A Thisted; Rory Childers; Stephen L Archer
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

6.  Repolarization Patterns in Congenital Heart Disease.

Authors:  Wael N Lotfy; Nashwa M Samra; Mohamed E Al Ghwass; Sayed A Amin; Sara I AboElnour
Journal:  Pediatr Cardiol       Date:  2016-06-10       Impact factor: 1.655

7.  Asthma in sickle cell disease: implications for treatment.

Authors:  Kathryn Blake; John Lima
Journal:  Anemia       Date:  2011-03-03

8.  Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension.

Authors:  N I Oguanobi; E C Ejim; B C Anisiuba; B J C Onwubere; S O Ike; O G Ibegbulam; O Agwu
Journal:  ISRN Hematol       Date:  2012-03-25

Review 9.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

10.  Cardiac autonomic dysfunction in sickle cell anaemia and its correlation with QT parameters.

Authors:  Philip Manma Kolo; Emmanuel Olatunde Sanya; Timothy O Olanrewaju; Ademola E Fawibe; Ayodele Soladoye
Journal:  Niger Med J       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.